BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18570437)

  • 1. The importance of the leader sequence for directing lanthionine formation in lacticin 481.
    Patton GC; Paul M; Cooper LE; Chatterjee C; van der Donk WA
    Biochemistry; 2008 Jul; 47(28):7342-51. PubMed ID: 18570437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide.
    Nagao J; Morinaga Y; Islam MR; Asaduzzaman SM; Aso Y; Nakayama J; Sonomoto K
    Peptides; 2009 Aug; 30(8):1412-20. PubMed ID: 19481127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutants of the zinc ligands of lacticin 481 synthetase retain dehydration activity but have impaired cyclization activity.
    Paul M; Patton GC; van der Donk WA
    Biochemistry; 2007 May; 46(21):6268-76. PubMed ID: 17480057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
    Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
    J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase.
    Chatterjee C; Patton GC; Cooper L; Paul M; van der Donk WA
    Chem Biol; 2006 Oct; 13(10):1109-17. PubMed ID: 17052615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the substrate specificity of lacticin 481 synthetase by using nonproteinogenic amino acids.
    Levengood MR; Kerwood CC; Chatterjee C; van der Donk WA
    Chembiochem; 2009 Mar; 10(5):911-9. PubMed ID: 19222036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic investigations of the dehydration reaction of lacticin 481 synthetase using site-directed mutagenesis.
    You YO; van der Donk WA
    Biochemistry; 2007 May; 46(20):5991-6000. PubMed ID: 17455908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 21. In vitro studies of lantibiotic biosynthesis.
    Li B; Cooper LE; van der Donk WA
    Methods Enzymol; 2009; 458():533-58. PubMed ID: 19374997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of amino acid substitutions in the nisin leader peptide on biosynthesis and secretion of nisin by Lactococcus lactis.
    van der Meer JR; Rollema HS; Siezen RJ; Beerthuyzen MM; Kuipers OP; de Vos WM
    J Biol Chem; 1994 Feb; 269(5):3555-62. PubMed ID: 8106398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
    Cotter PD; Deegan LH; Lawton EM; Draper LA; O'Connor PM; Hill C; Ross RP
    Mol Microbiol; 2006 Nov; 62(3):735-47. PubMed ID: 17076667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
    Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
    Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.
    Escano J; Stauffer B; Brennan J; Bullock M; Smith L
    J Bacteriol; 2015 Apr; 197(7):1173-84. PubMed ID: 25605307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a Novel Lantibiotic Using Mutacin II Biosynthesis Apparatus.
    Biswas S
    Microbiol Spectr; 2023 Feb; 11(1):e0303022. PubMed ID: 36645288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of amino acid substitutions in conserved residues in the leader peptide on biosynthesis of the lantibiotic mutacin II.
    Chen P; Qi FX; Novak J; Krull RE; Caufield PW
    FEMS Microbiol Lett; 2001 Feb; 195(2):139-44. PubMed ID: 11179642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro catalytic activity of N-terminal and C-terminal domains in NukM, the post-translational modification enzyme of nukacin ISK-1.
    Shimafuji C; Noguchi M; Nishie M; Nagao J; Shioya K; Zendo T; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2015 Dec; 120(6):624-9. PubMed ID: 25971839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics.
    Escano J; Stauffer B; Brennan J; Bullock M; Smith L
    Microbiologyopen; 2014 Dec; 3(6):961-72. PubMed ID: 25400246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology of lantibiotics from the lacticin 481 group is coming of age.
    Dufour A; Hindré T; Haras D; Le Pennec JP
    FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leader Peptide Establishes Dehydration Order, Promotes Efficiency, and Ensures Fidelity During Lacticin 481 Biosynthesis.
    Thibodeaux CJ; Wagoner J; Yu Y; van der Donk WA
    J Am Chem Soc; 2016 May; 138(20):6436-44. PubMed ID: 27123925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dehydratase activity of lacticin 481 synthetase is highly processive.
    Miller LM; Chatterjee C; van der Donk WA; Kelleher NL
    J Am Chem Soc; 2006 Feb; 128(5):1420-1. PubMed ID: 16448091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variacin, a new lanthionine-containing bacteriocin produced by Micrococcus varians: comparison to lacticin 481 of Lactococcus lactis.
    Pridmore D; Rekhif N; Pittet AC; Suri B; Mollet B
    Appl Environ Microbiol; 1996 May; 62(5):1799-802. PubMed ID: 8633879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.